The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-allyl-N-(3-((2-(3-bromo-4-morpholinophenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide ID: ALA3965256
PubChem CID: 134150465
Max Phase: Preclinical
Molecular Formula: C25H27BrF3N7O3S
Molecular Weight: 642.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CCN(c1ncccc1CNc1nc(Nc2ccc(N3CCOCC3)c(Br)c2)ncc1C(F)(F)F)S(C)(=O)=O
Standard InChI: InChI=1S/C25H27BrF3N7O3S/c1-3-9-36(40(2,37)38)23-17(5-4-8-30-23)15-31-22-19(25(27,28)29)16-32-24(34-22)33-18-6-7-21(20(26)14-18)35-10-12-39-13-11-35/h3-8,14,16H,1,9-13,15H2,2H3,(H2,31,32,33,34)
Standard InChI Key: IPFKLMTZBQTUDC-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
14.8412 -5.8295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0242 -5.8440 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.4453 -6.5443 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6332 -1.3867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6321 -2.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3401 -2.6152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0498 -2.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0470 -1.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3384 -0.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7504 -0.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3930 -0.5977 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.5498 -1.2724 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.8835 -0.1283 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.7582 -2.6132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7740 -3.4303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4895 -3.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5007 -4.6395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2154 -5.0342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9160 -4.6119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8974 -3.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1823 -3.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9235 -2.6151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7997 -5.0596 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9825 -5.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5830 -5.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7659 -5.7933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4562 -6.4316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9165 -3.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2052 -3.8291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1979 -4.6430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9004 -5.0572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6118 -4.6516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6157 -3.8390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4865 -5.0452 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
10.8945 -5.8744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1818 -6.2732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1740 -7.0868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8769 -7.5044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5893 -7.1021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5989 -6.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 12 1 0
10 13 1 0
8 10 1 0
7 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 23 1 0
5 22 1 0
23 24 1 0
23 2 1 0
24 25 1 0
25 26 2 0
2 27 1 0
22 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
30 34 1 0
31 35 1 0
35 36 1 0
35 40 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 642.50Molecular Weight (Monoisotopic): 641.1032AlogP: 4.80#Rotatable Bonds: 10Polar Surface Area: 112.58Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.57CX LogP: 4.20CX LogD: 4.20Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.30Np Likeness Score: -1.79
References 1. Farand J, Mai N, Chandrasekhar J, Newby ZE, Van Veldhuizen J, Loyer-Drew J, Venkataramani C, Guerrero J, Kwok A, Li N, Zherebina Y, Wilbert S, Zablocki J, Phillips G, Watkins WJ, Mourey R, Notte GT.. (2016) Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency., 26 (24): [PMID:27876318 ] [10.1016/j.bmcl.2016.10.092 ]